DE3683956D1 - In einem serumfreien medium in suspension kultivierte humane monozyten. - Google Patents

In einem serumfreien medium in suspension kultivierte humane monozyten.

Info

Publication number
DE3683956D1
DE3683956D1 DE8686401250T DE3683956T DE3683956D1 DE 3683956 D1 DE3683956 D1 DE 3683956D1 DE 8686401250 T DE8686401250 T DE 8686401250T DE 3683956 T DE3683956 T DE 3683956T DE 3683956 D1 DE3683956 D1 DE 3683956D1
Authority
DE
Germany
Prior art keywords
suspension
human monocytes
serum
free medium
monocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686401250T
Other languages
English (en)
Inventor
Henry C Stevenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce filed Critical US Department of Commerce
Application granted granted Critical
Publication of DE3683956D1 publication Critical patent/DE3683956D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4614—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/056—Immunostimulating oligonucleotides, e.g. CpG
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
DE8686401250T 1985-06-11 1986-06-10 In einem serumfreien medium in suspension kultivierte humane monozyten. Expired - Lifetime DE3683956D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74357085A 1985-06-11 1985-06-11

Publications (1)

Publication Number Publication Date
DE3683956D1 true DE3683956D1 (de) 1992-04-02

Family

ID=24989299

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686401250T Expired - Lifetime DE3683956D1 (de) 1985-06-11 1986-06-10 In einem serumfreien medium in suspension kultivierte humane monozyten.

Country Status (5)

Country Link
EP (1) EP0205387B1 (de)
JP (1) JP2581673B2 (de)
AT (1) ATE72829T1 (de)
CA (1) CA1306966C (de)
DE (1) DE3683956D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093115A (en) * 1985-06-11 1992-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of preparing activated killer monocytes for treating colorectal cancer
FR2657783B1 (fr) * 1990-02-07 1992-05-29 Fondation Nale Transfusion San Procede de preparation de derives sanguins et derives obtenus par ce procede.
JPH04170965A (ja) * 1990-11-01 1992-06-18 Nippon Koutai Kenkyusho:Kk リンパ球の活性化方法
AU2882992A (en) * 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
DK0559425T3 (da) * 1992-03-02 1999-08-30 Japan Immuno Inc Anvendelse af proteiner tilhørende transferrin/lactoferrinfamilien til stimulering af immunsystemet
US5583053A (en) * 1992-07-21 1996-12-10 Kim; Think Y. Macrophage cell line for use in the detection of antinuclear antibodies
JP3264142B2 (ja) * 1995-06-08 2002-03-11 富士通株式会社 Ｐｌｌ制御方式
BRPI0407900A (pt) 2003-02-27 2006-03-21 Northwest Biotherapeutics Inc geração de células dendrìticas de células precursoras dentrìticas monocìticas com gm-csf na ausência de citocinas adicionais
KR101111231B1 (ko) * 2003-09-25 2012-02-17 비바리스 마이크로 웰 어레이 칩 및 그 제조방법
CN100460504C (zh) * 2006-12-13 2009-02-11 青岛市中心医院 一种增加单核细胞贴壁数量的方法

Also Published As

Publication number Publication date
JP2581673B2 (ja) 1997-02-12
CA1306966C (en) 1992-09-01
JPS6265682A (ja) 1987-03-24
ATE72829T1 (de) 1992-03-15
EP0205387A2 (de) 1986-12-17
EP0205387B1 (de) 1992-02-26
EP0205387A3 (en) 1989-03-15

Similar Documents

Publication Publication Date Title
AU7873187A (en) Method of culturing leukocytes
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
ATE20073T1 (de) Homogenes human-interleukin-2 und verfahren zu seiner herstellung.
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
NZ225362A (en) Optical isomers of medetomidine and pharmaceutical compositions
NO161573C (no) Fremgangsmaate til fremstilling av hyaluronsyre.
ES2103706T3 (es) Receptores de interleuquina-4.
DE69533941D1 (de) Verfahren zur herstellung eines arzneimittels zur behandlung des sekundärimmunmangels
DE3683956D1 (de) In einem serumfreien medium in suspension kultivierte humane monozyten.
PT86687A (pt) Process for the preparation of novel polyamine derivatives
AU2760288A (en) In vitro culture of bovine embryos
KR890700609A (ko) 정제된 혈소판으로 부터 유도한 성장 인자 및 그의 정제방법
US4411992A (en) Process for preparing murine interleukin 2
IT8867773A0 (it) Lai e simili sistema per il controllo del trasporto di parti sostitutive per te
PT87503A (pt) Process for the preparation of new cathecolamine by products
FR2620131B1 (fr) Procede de production de carotenoides et notamment d'astaxanthine par culture de microalgues et dispositif pour la mise en oeuvre du procede
EP0491851A4 (en) Method for the production of in vitro expanded lymphoid cells for use in adoptive immunotherapy
ES2061558T3 (es) Sondas de hibridacion de acidos nucleicos de papilomavirus humanos y metodos para su empleo.
EP0299067A4 (de) Zuchtmedium für pflanzen.
NO922304L (no) Eliminering av aktiverte lymfocytter
FR2587359B1 (fr) Derives non amides de la somatocrinine et procede de preparation par genie genetique
IT1217825B (it) Procedimento ed impianto per la coltura di microorganismi
FR2583047B1 (fr) Procede de preparation de derives du 4-phenylpropyl indole, et intermediaires
IT1206039B (it) Procedimento per la produzione di etanolo mediante ceppi di microorganismo ad elevata resistenza
MD73B1 (ro) Instalatie pentru cultivarea microalgelor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition